Exploring the Key Drivers of Financial Performance in the Context of Corporate and Public Governance: Empirical Evidence
This research focuses on analyzing the determinants of financial performance for the companies included in the Standard & Poor’s 500 index over the period from 2014 to 2023. To guide managerial decisions aimed at enhancing company performance, this study examines, as key drivers, the main financial indicators, core corporate governance characteristics, and U.S. public governance indicators. The investigation begins with a retrospective review of the specialized literature, highlighting the findings of previous studies in the field and providing the basis for selecting the variables used in the present empirical analysis. The research method employed is fixed-effects panel-data regression. The dependent variables are financial performance measures, such as the EBITDA margin, EBIT margin, net profit margin, and ROA. This study’s main results show that the price-to-book ratio, liquidity, sales growth, CEO duality, board gender diversity, ESG score, and U.S. regulatory quality exert a positive influence on financial performance. In contrast, the price-to-earnings ratio, net debt, capital intensity, R&D intensity, weighted average cost of capital, board independence, and the COVID-19 pandemic crisis have a negative impact on the financial performance of U.S. companies. The findings of this investigation could serve as benchmarks for supporting managerial decisions at the company level regarding the improvement of their financial performance.
Institutions
- Alexandru Ioan Cuza University (RO)
- Bucharest University of Economic Studies (RO)
Publication Details
- Journal
- Information
- Published
- 2025-08-14
- DOI
- https://doi.org/10.3390/info16080691
- Citations
- 2
- Primary Topic
- Lymphoma Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 2.94